CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 230,298,252	$ 106,891,503
Restricted cash	20,150	0
Investment in marketable securities	1,154,480	1,127,102
Receivables, net	19,731,189	7,127,217
Receivables, net – related parties	37,708,178	49,328,739
Other receivables	15,527,520	1,003,133
Prepaid expenses and other current assets	10,495,938	7,385,098
Loans receivable - related parties	6,425,000	0
Total current assets	321,360,707	172,862,792
Noncurrent assets
Land, property and equipment, net	12,427,107	12,721,082
Intangible assets, net	114,166,305	86,875,883
Goodwill	237,134,772	185,805,880
Loans receivable – related parties, net of current portion	12,500,000	17,500,000
Investment in other entities – equity method	35,840,105	34,876,980
Investment in a privately held entity that does not report net asset value per share	896,000	405,000
Restricted cash	746,104	745,470
Right-of-use assets	13,540,129
Other assets	1,633,153	1,205,962
Total noncurrent assets	428,883,675	340,136,257
Total assets	750,244,382	512,999,049
Current liabilities
Accounts payable and accrued expenses	35,539,917	25,075,489
Fiduciary accounts payable	1,734,142	1,538,598
Medical liabilities	53,819,647	33,641,701
Income taxes payable	1,392,492	11,621,861
Bank loan	0	40,257
Dividend payable	271,279
Finance lease liabilities	101,741	101,741
Operating lease liabilities	2,836,010
Current portion of long term debt	9,500,000
Total current liabilities	105,195,228	72,019,647
Noncurrent liabilities
Lines of credit – related party	0	13,000,000
Deferred tax liability	30,199,423	19,615,935
Liability for unissued equity shares	1,185,025	1,185,025
Finance lease liabilities	441,241	517,261
Operating lease liabilities	10,670,364	0
Long-term debt, net of current portion and deferred financing costs	234,149,063	0
Total noncurrent liabilities	276,645,116	34,318,221
Total liabilities	381,840,344	106,337,868
Commitments and Contingencies (Note 11)
Mezzanine equity
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (“APC”)	176,230,074	225,117,029
Stockholders’ equity
Common stock, $0.001 par value; 100,000,000 shares authorized, 34,822,933 and 34,578,040 shares outstanding, excluding 16,959,069 and 1,850,603 treasury shares, at September 30, 2019 and December 31, 2018, respectively	34,823	34,578
Additional paid-in capital	165,521,888	162,723,051
Retained earnings	25,177,257	17,788,203
Retained earnings	190,733,968	180,545,832
Noncontrolling interest	1,439,996	998,320
Total stockholders’ equity	192,173,964	181,544,152
Total liabilities, mezzanine equity and stockholders’ equity	750,244,382	512,999,049
Series A Preferred stock, $0.001 par value; 5,000,000 shares authorized (inclusive of all preferred stock, including Series B Preferred stock); 1,111,111 issued and zero outstanding at September 30, 2019 and December 31, 2018, respectively
Stockholders’ equity
Preferred stock	0	0
Series B Preferred stock, $0.001 par value; 5,000,000 shares authorized (inclusive of all preferred stock, including Series A Preferred stock); 555,555 issued and zero outstanding at September 30, 2019 and December 31, 2018, respectively
Stockholders’ equity
Preferred stock	$ 0	$ 0